Arie Belldegrun Transaction History

Date Transaction Value Shares Traded Form
May 16 2024
BUY
Open market or private purchase
$4,999,997 $2.9 p/Share
1,724,137
May 16 2024
BUY
Grant, award, or other acquisition
$1,000,001 $2.9 p/Share
344,828
Mar 14 2022
SELL
Other acquisition or disposition
-
4,710,121
Mar 14 2022
BUY
Other acquisition or disposition
-
4,710,121
Jan 12 2022
BUY
Open market or private purchase
$1,953,491 $12.6 p/Share
155,039

Also insider at

KRON
Kronos Bio, Inc. Healthcare
URGN
UroGen Pharma Ltd. Healthcare
DNA
Ginkgo Bioworks Holdings, Inc. Healthcare
AB

Arie Belldegrun

Director
Princeton, NJ

Track Institutional and Insider Activities on ALLO

Follow Allogene Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALLO shares.

Notify only if

Insider Trading

Get notified when an Allogene Therapeutics, Inc. insider buys or sells ALLO shares.

Notify only if

News

Receive news related to Allogene Therapeutics, Inc.

Track Activities on ALLO